Your browser doesn't support javascript.
loading
Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES.
Chiang, Chern-En; Schwartz, Gregory G; Elbez, Yedid; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Erglis, Andrejs; Goodman, Shaun G; Hagström, Emil; Jukema, J Wouter; Liberopoulos, Evangelos; Loy, Megan; Pordy, Robert; White, Harvey D; Simon, Tabassome; Steg, Philippe Gabriel.
Affiliation
  • Chiang CE; General Clinical Research Center, Division of Cardiology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taipei, Taiwan. Electronic address: cechiang@vghtpe.gov.tw.
  • Schwartz GG; University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Elbez Y; Deepscover, Puteaux, France.
  • Szarek M; State University of New York, Downstate School of Public Health, Brooklyn, New York, USA; CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
  • Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Diaz R; Estudios Cardiológicos Latino América, Instituto Cardiovascular de Rosario, Rosario, Argentina.
  • Erglis A; Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia.
  • Goodman SG; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Hagström E; Department of Medical Sciences, and Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
  • Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Liberopoulos E; Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
  • Loy M; Sanofi, Bridgewater Township, New Jersey, USA.
  • Pordy R; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • White HD; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand.
  • Simon T; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Paris, France.
  • Steg PG; Department of Cardiology, Université de Paris, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris, France; FACT (French Alliance for Cardiovascular Trials), Paris, France; INSERM U1148, Paris, France; Imperial College, Royal Brompton Hospital, London, United Kingdom.
Can J Cardiol ; 38(10): 1542-1549, 2022 10.
Article in En | MEDLINE | ID: mdl-35644332
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome / Myocardial Infarction Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Can J Cardiol Journal subject: CARDIOLOGIA Year: 2022 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome / Myocardial Infarction Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Can J Cardiol Journal subject: CARDIOLOGIA Year: 2022 Document type: Article Country of publication: United kingdom